INS and type 2 diabetes mellitus: Subsequently, application of a recombinant human IL-1Ra (anakinra) was found to effectively reduce the rate of insulitis in animal models of T2D and patients, that was reflected by the increased insulin to proinsulin plasma ratio, improvement of blood glucose control and peripheral insulin sensitivity (see below) [78].